Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2
- PMID: 35775166
- PMCID: PMC9254723
- DOI: 10.12659/MSM.937676
Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2
Abstract
On 26 November 2021, the World Health Organization (WHO) identified the B.1.1.529 variant, or Omicron variant, as the fifth variant of concern (VOC) of SARS-CoV-2. The B.1.1.529 Omicron variant of SARS-CoV-2 includes five lineages, BA.1, BA.2, BA.3, BA.4. and BA.5. During the past six months, several identified sublineages of B.1.1.529 have rapidly spread globally. Although the lineages BA.1 and BA.2 initially predominated, BA.4, BA.5, and sublineage BA.2.12.1 are now dominant in Europe and the USA. On 12 May 2022, the European Centre for Disease Prevention and Control (ECDC) reclassified BA.4 and BA.5 from variants of interest (VOI) to variants of concern (VOC). BA.2.12.1, BA.4, and BA.5 have shown higher transmissibility and increased neutralization evasion compared with BA.2 when tested against plasma from patients with triple-vaccination and following infection with BA.1. On 7 June 2022, the World Health Organization (WHO) added a new category to its SARS-CoV-2 variant tracking system, the VOC Lineages Under Monitoring (VOC-LUM), which aims to inform global public health authorities of the VOC lineages and sublineages that may require prioritized attention and monitoring. This Editorial aims to present an update on the lineages and sublineages of the Omicron variant of SARS-CoV-2 and the VOC-LUM initiative from the WHO.
Conflict of interest statement
Similar articles
-
In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.J Med Virol. 2023 Jan;95(1):e28241. doi: 10.1002/jmv.28241. Epub 2022 Nov 8. J Med Virol. 2023. PMID: 36263448 Free PMC article.
-
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580. Med Sci Monit. 2023. PMID: 36722047 Free PMC article.
-
Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies.Int J Surg Open. 2023 Jun;55:100625. doi: 10.1016/j.ijso.2023.100625. Epub 2023 May 18. Int J Surg Open. 2023. PMID: 37255735 Free PMC article.
-
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.Signal Transduct Target Ther. 2022 Jul 19;7(1):241. doi: 10.1038/s41392-022-01105-9. Signal Transduct Target Ther. 2022. PMID: 35853878 Free PMC article. Review.
-
The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity.J Med Virol. 2023 Jan;95(1):e28138. doi: 10.1002/jmv.28138. Epub 2022 Sep 21. J Med Virol. 2023. PMID: 36097349 Free PMC article. Review.
Cited by
-
Global Distribution, Dispersal Patterns, and Trend of Several Omicron Subvariants of SARS-CoV-2 across the Globe.Trop Med Infect Dis. 2022 Nov 12;7(11):373. doi: 10.3390/tropicalmed7110373. Trop Med Infect Dis. 2022. PMID: 36422924 Free PMC article.
-
Editorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is Declared.Med Sci Monit. 2023 Nov 1;29:e942960. doi: 10.12659/MSM.942960. Med Sci Monit. 2023. PMID: 37908161 Free PMC article.
-
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.Clin Infect Dis. 2024 May 15;78(5):1194-1203. doi: 10.1093/cid/ciad718. Clin Infect Dis. 2024. PMID: 38016021 Free PMC article. Clinical Trial.
-
Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir.Med Sci Monit. 2022 Oct 1;28:e938532. doi: 10.12659/MSM.938532. Med Sci Monit. 2022. PMID: 36181334 Free PMC article.
-
Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.Int J Med Sci. 2023 Jan 1;20(1):151-162. doi: 10.7150/ijms.79116. eCollection 2023. Int J Med Sci. 2023. PMID: 36619228 Free PMC article. Review.
References
-
- World Health Organization (WHO) Technical Report. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Nov 26, 2021. Available from https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.....
-
- World Health Organization (WHO) Technical Report. Enhancing Response to Omicron SARS-CoV-2 variant. Jan 21, 2022. Available from https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-....
-
- Statista. Number of SARS-CoV-2 Omicron variant cases worldwide by country or territory. 2022 June 20;
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous